[Federal Register: August 13, 2009 (Volume 74, Number 155)]
[Notices]               
[Page 40822]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr13au09-47]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Health Promotion and Disease Prevention Research 
Centers, Special Interest Project Competitive Supplements (SIPS) (U48 
Panels N, O and P), RFA-DP09-101SUPP09, Initial Review

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the aforementioned meeting.

    Time and Dates:

9 a.m.-5 p.m., August 5, 2009 (closed).
9 a.m.-5 p.m., August 6, 2009 (closed).
9 a.m.-5 p.m., August 7, 2009 (closed).

    Place: Westin Hotel, 3377 Peachtree Road, NE., Atlanta, GA, 
30326, Telephone (678) 500-3100.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of the application received in response 
to ``Health Promotion and Disease Prevention Research Centers, 
Special Interest Project Competitive Supplements (SIPS) (U48 Panels 
N, O and P), RFA-DP09-101SUPP09, initial review.''
    Contact Person for More Information: Brenda Colley-Gilbert, 
Ph.D., Director, Extramural Research Program Office, CCH, 47770 
Buford Highway, MS K-92, Atlanta, GA 30341, Telephone (770) 488-
8390.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E9-19293 Filed 8-12-09; 8:45 am]

BILLING CODE 4163-18-P